Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07524270 · ClinicalTrials.gov registry record · NA
Effera Dose Response: Women's Health
A NA study, sponsored by Helaina.
- Recruiting
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT07524270 is a NA study that is actively recruiting participants, run by Helaina. The registered enrollment target is 160 participants.
The verdict
NCT07524270, a NA study, is actively recruiting participants, sponsored by Helaina.
- RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if a human equivalent lactoferrin supplement (effera®) can improve menstrual symptoms, mood, and quality of life in healthy women aged 18-40. The main questions it aims to answer are: Does effera® reduce the severity of menstrual symptoms? Does effera® improve mood, gastrointestinal symptoms, and overall well-being? Researchers will compare three different doses of effera® to a placebo (a look-alike supplement with no active ingredient) to see if the supplement improves these outcomes. Participants will: Take the assigned supplement (effera® or placebo) daily for 12 weeks Complete online questionnaires about menstrual symptoms, mood, and health Optionally share sleep and activity data from a wearable device
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Effera® (human equivalent lactoferrin)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2026-04 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07524270
The ClinicalTrials.gov registry entry for NCT07524270 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Helaina, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07524270 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07524270 about?
NCT07524270 is a clinical study titled "Effera Dose Response: Women's Health". The goal of this clinical trial is to learn if a human equivalent lactoferrin supplement (effera®) can improve menstrual symptoms, mood, and quality of life in healthy women aged 18-40. The main questions it aims to answer are: Does effera® reduce the severity of menstrual symptoms? Does effera® ...
What is the current status of trial NCT07524270?
This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2026-04. Estimated completion is 2026-12.
What interventions are being tested in trial NCT07524270?
The interventions under investigation include: Placebo (OTHER), Effera® (human equivalent lactoferrin) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07524270?
This trial is sponsored by Helaina, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.